RFL News and Press, Rafael Holdings Inc. Class B From 04/16/21

Rafael Holdings Announces Inducement Grant Under NYSE Rule 303A.08 PR Newswire NEWARK, N.J. , April 16, 2021 /PRNewswire/ -- Rafael Holdings, Inc., (NYSE: RFL), today announced that on April 15, 2021 it made a grant to William Conkling of options to purch...

Rafael Pharmaceuticals (RFL) announces that it has crossed the enrollment of 150 patients in its Phase 3 clinical trial for patients with relapsed or refractory acute myeloid leukemia ((AML)).The multicenter, open-label, randomized pivotal trial is assessing the efficacy and safety of Ra...

CRANBURY, N.J., March 30, 2021 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc. (“Rafael” or the “Company”), a leader in the growing field of cancer metabolism-based therapeutics, today announced that it has crossed the enrollment of 150 patients in its Phase...

Rafael Holdings (RFL): FQ2 GAAP EPS of -$0.50.Revenue of $1M (-19.4% Y/Y)Shares +5.4%.Press Release For further details see: Rafael Holdings reports FQ2 results

Rafael Holdings Reports Second Quarter Fiscal Year 2021 Results PR Newswire NEWARK, N.J. , March 17, 2021 /PRNewswire/ -- Rafael Holdings, Inc., (NYSE: RFL), reported revenue of $1.0 million and a loss per share of $0.50 for the second quarter of its...

Gainers: NLS Pharmaceutics NLSP +111%, Entera Bio ENTX +75%, Seelos Therapeutics SEEL +34%, Regulus Therapeutics (RGLS) +27%, Rafael (RFL) +27%.Losers: Marker Therapeutics MRKR -28%, Timber Pharmaceuticals (TMBR) -21%, Evoke Pharma EVOK&#...

Rafael Holdings Enhances Senior Management Team with Additions of Ameet Mallik, CEO and William Conkling, CCO Leadership Team Will Build on Pharma Investments PR Newswire NEWARK, N.J. , March 11, 2021 /PRNewswire/ -- Rafael Holdings, Inc., (NYSE: RFL), t...

Gainers: Sunesis Pharmaceuticals (SNSS) +38%, Owens & Minor (OMI) +32%, Salarius Pharmaceuticals (SLRX) +20%, Poseida Therapeutics (PSTX) +20%, PRA Health Sciences (PRAH) +19%.Losers: Rafael (RFL) -12%, Constellation Pharmaceuticals (CNST)...

Kahn Brothers’ 13F portfolio value increased from $528M to $579M this quarter. New York Community Bancorp, VOXX International, BlackBerry, and Patterson-UTI Energy were decreased during the quarter. The portfolio continues to be very concentrated with the top five positions...

JERUSALEM, Israel, Feb. 10, 2021 (GLOBE NEWSWIRE) -- LipoMedix , a clinical-stage, oncology-focused pharmaceutical company involved in the development of innovative, safe and effective cancer therapy based on a pegylated liposomal drug delivery platform, today announced that its lea...